DoMore Diagnostics announced that it received CE mark approval in Europe for its Histotype Px Colorectal deep learning algorithm.
Oslo, Norway-based DoMore designed its Histotype Px Colorectal deep learning algorithm to predict colorectal cancer patient outcomes based on analysis of digital histology images.
The company said in a news release that the algorithm, which builds on research led by the Institute for Cancer Genetics and Informatics at Oslo University Hospital, represents the first CE-marked product to utilize artificial intelligence (AI) to predict patient outcomes based on advanced image analysis.
Analysis with the Histotype Px Colorectal deep learning algorithm is conducted on high-resolution scans from standard H&E stained slides to provide shorter turnaround times, DoMore Diagnostics said.
Results from an early version of the algorithm were published in The Lancet, while the company has spent the last year applying improvements …